ArticlePloS one2018

Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.

Ayguen Sahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.